The present invention provides a tissue-targeting complex comprising a tissue targeting moiety, an octadentate hydroxypyridinone-containing ligand and the ion of an alpha-emitting thorium radionuclide. The invention additionally provides pharmaceutical compositions comprising such complexes, as well as said complexes and compositions for use in treating hyperplastic or neoplastic diseases.